{"member_organisations": "", "identification_number": "934069612666-51", "fields_of_interest": "General and Institutional Affairs, Economy, finance and the euro, Trade, Competition, Employment and Social Affairs, Business and Industry, Single market, Research and innovation, Public Health, Digital economy and society", "head_office_address": "North Waukegan Road, 1", "full_time_equivalent_fte": "1,25", "person_with_legal_responsibility": "Richard A. Gonzalez", "industry_forums": "", "grants": "", "country_code": "us", "inter_groups": "", "eu_initiatives": "- Implementation of the regulation on Clinical Trials \n- Implementation of the legislation on Falsified Medicines \n- Joint Procurement for medical countermeasures \n- Commission expert group on safe and timely access for patients \n- Prevention and Early Intervention in Chronic Diseases \n- Demographic change and healthy ageing \n- Competition in the pharmaceutical sector \n- Pharmaceutical industrial policy including intellectual property policies \n- Revision of Medical Device and IVD Regulation \n- European Commission activities around ensuring effective, resilient and sustainable healthcare systems \n- Access to Medicines", "level_of_interest": "global", "organisation_name": "AbbVie", "belgium_office_post_code": "1000", "number_of_persons_involved": "5", "person_in_charge_of_eu_relations": "Ludovic Lacaine", "section": "II - In-house lobbyists and trade/business/professional associations", "lon": "-87.8881326", "source": "", "subsection": "Companies & groups", "belgium_office_phone": "(+32)027917702", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "Regus Offices - offices 507-508 Square de Meeus 37", "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "20/01/2014", "estimate_of_costs_absolute_amount": "", "website_address": "http://www.abbvie.com", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "North Chicago", "membership": "- American Chamber of Commerce to the EU \n- European Federation of Pharmaceutical Industries and Association (EFPIA) \n- European Biopharmaceutical Enterprises (EBE) \n- EuropaBio \u2013 the European Association of Bio-Industries \n- CSR Europe", "head_office_post_code": "IL 60064", "position": "Government Affairs Director, Brussels/EU", "financial_year_start_date": "01/01/2017", "head_office_country": "United States", "number_of_ep_accredited_persons": "", "relevant_communication": "Sustainable Healthcare Initiative: multi-stakeholder initiative (patients, healthcare professionals, academia, policy makers, economists and industry) that looks into improving the sustainability of our healthcare systems by piloting solutions, ensuring the scale up of these and relevant policy endorsement and input at EU and national level.", "financial_year_end_date": "01/12/2017", "lat": "42.2932732", "estimate_of_costs_as_a_range": "400000-499999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "AbbVie inc.", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "AbbVie is a Specialty-focused, research-based biopharmaceutical company. \n \nWe are approximately 25,000 people focused on developing new products and new ways to help people manage some of the most serious health conditions. We are scientists, researchers, communicators, manufacturing specialists, and regulatory experts. \n \nAbbVie began as the pharmaceutical leader, Abbott, which was founded in 1888 by Chicago physician, Dr. Wallace Abbott. Since then, Abbott has evolved to become a global healthcare leader, delivering innovative pharmaceutical, nutritional, diagnostic, and medical products to people in more than 150 countries. \n \nOn January 1, 2013, AbbVie was founded, a global biopharmaceutical company with the focus and capabilities to address some of the world's greatest health challenges. AbbVie has the stability, resources, expertise, and passion to discover, develop, and bring to market groundbreaking science to solve the biggest health problems that face the world today and tomorrow.", "belgium_office_city": "Brussels", "head_office_phone": "(+32)10 47 78 41"}